Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.72, moving -3.13% from the previous trading session ...
Which Is a Better Investment, Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. Stock?
Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...
At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...
Zacks Investment Research on MSN
3 cancer stocks to watch as oncology innovation accelerates
An updated edition of the May 18, 2026, article. The global oncology market is evolving rapidly, fueled by rising cancer incidence, an aging population and continued scientific innovation. According ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Get the latest news and real-time alerts from Recursion Pharmaceuticals, Inc. (RXRX) stock at Seeking Alpha.
Get detailed forecast and price target charts for Recursion Pharmaceuticals, Inc. stock on Seeking Alpha. Click here to see the forecast for RXRX stock ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Cathie Wood bought over $2 million of stock in CoreWeave, a Nvidia-backed cloud infrastructure company. Learn more about her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results